ChartMill assigns a fundamental rating of 3 / 10 to PTLA.
ChartMill assigns a valuation rating of 0 / 10 to Portola Pharma (PTLA). This can be considered as Overvalued.
Portola Pharma (PTLA) has a profitability rating of 2 / 10.
The financial health rating of Portola Pharma (PTLA) is 3 / 10.